Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

AT(1)-receptor blockers: differences that matter.

A H Gradman1

  • 1Division of Cardiovascular Diseases, The Western Pennsylvania Hospital, Pittsburgh 15224, USA.

Journal of Human Hypertension
|July 26, 2002
PubMed
Summary

Angiotensin II type 1 receptor blockers vary in efficacy. Candesartan shows superior receptor binding and a longer duration of action compared to losartan, offering extended antihypertensive coverage.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy, safety and tolerability of aliskiren, a direct renin inhibitor, in women with hypertension: a pooled analysis of eight studies.

Journal of human hypertension·2010
Same author

Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage I-II hypertension.

Journal of human hypertension·2009
Same author

Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension.

International journal of clinical practice·2007
Same author

Comparative effects of candesartan cilexetil and losartan in patients with systemic hypertension. Candesartan Versus Losartan Efficacy Comparison (CANDLE) Study Group.

Heart disease (Hagerstown, Md.)·2001
Same author

Underutilization and clinical benefits of angiotensin-converting enzyme inhibitors in patients with asymptomatic left ventricular dysfunction.

The American journal of cardiology·2000
Same author

Long-term benefits of angiotensin II blockade: is the consensus changing?

The American journal of cardiology·1999

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine

Background:

  • Angiotensin II type 1 (AT(1))-receptor blockers exhibit diverse pharmacological profiles and clinical effectiveness.
  • Losartan acts as a surmountable antagonist, while other agents function as insurmountable antagonists with varying degrees of maximal response suppression.

Purpose of the Study:

  • To compare the pharmacological properties and clinical efficacy of different AT(1)-receptor blockers.
  • To investigate the relationship between receptor binding affinity, maximal antihypertensive effect, and duration of action.

Main Methods:

  • Receptor binding studies were conducted to determine the affinity and dissociation rates of various AT(1)-receptor blockers.
  • A meta-analysis using an E(Max) model evaluated the correlation between receptor binding activity and maximal antihypertensive effects.
  • Comparative clinical trials assessed the duration of action of candesartan versus losartan.

Main Results:

  • Candesartan demonstrated the highest affinity for the AT(1)-receptor, with slower dissociation compared to irbesartan, valsartan, and losartan.
  • Differences in receptor binding correlated with variations in maximal antihypertensive effect and response rates.
  • Candesartan's prolonged receptor binding resulted in a 48-hour duration of action, significantly longer than losartan's approximately 24-hour effect.

Conclusions:

  • Pharmacological distinctions among AT(1)-receptor blockers translate into clinically significant differences in maximal antihypertensive effect, response rate, and duration of action.
  • Candesartan's extended duration of action provides improved therapeutic coverage, which is crucial for patient adherence.
  • Current evidence does not indicate that receptor binding differences impact tolerability among these agents.

Related Experiment Videos